Physicians’ Perception of the Patient Care Pathway for Acute Heart Failure in Asian Countries: Implications for Resource Allocation, Preventive Strategies and Clinical Trial Design
Elvira Zenaida Lansang, David Horsburgh, Yun Ning Lee, Adeline Sng, Ralph Moussalli, Karen Wai, Inder Anand, Shu Zhang, Wataru Shimizu and 9 more
10 December 2014
October 2014, 22:15
1.Sakata Y, Shimokawa H. Epidemiology of HF in Asia. Circ J 2013;77:2209–2217.
2.Mosterd A, Hoes AW. Clinical epidemiology of HF. Heart 2007;93:1137–1146.
3.Forouzanfar MH, Moran A, Phillips D, Mensah G, Ezzati M, Naghavi M, et al. Prevalence of HF by cause in 21 regions: global burden of diseases, injuries and risk factors - 2010 Study. J Am Coll Cardiol 2013;61(10_S).
4.Lam CSP, Donal E, Krainer EK, Vasan RS. Epidemiology and clinical course of HF with preserved ejection fraction. Eur J Heart Fail 2011;13(1):18–28.
5.Yang YN, Ma YT, Liu F, Li XM, Huang Y, Tang Q, et al. Incidence and distributing feature of chronic heart failure in adult population of Xinjiang. Zhonghua Xin Xue Guan Bing Za Zhi. 2010:38(5):460–4.
6.Ng TP, Niti M. Trends and ethnic differences in hospital admissions and mortality for congestive heart failure in the elderly in Singapore, 1991 to 1998. Heart. 2003;89:865–870.
7.Lee S, Khurana R, Leong KTG. Heart failure in Asia: the present reality and future challenges. Eur Heart J Suppl 2012;14(suppl A):A51–A52.
8.Lansang EZ, Tang V, Ranade S, Caveney E, Ng N, Saldanha LM, et al. The patient care pathway for type 2 diabetes mellitus in Asian countries: implications on target physician group for diabetes clinical trials. J Diabetes Metab 2014;5:331.
9.Adams KF Jr., Fonarow GC, Emerman CL, LeJemtel TH, Constanzo MR, Abraham WT, et al. Characteristics and outcomes of patients hospitalized for HF in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the acute decompensated HF national registry (ADHERE). Am Heart J 2005;149(2):209–216
10.Atherton JJ, Hayward CS, Ahmad WAW, Kwok B, Jorge J, Hernandez AF, et al. Patient characteristics from a regional multicenter database of acute decompensated HF in Asia Pacific (ADHERE International - Asia Pacific). J Card Fail 2012;18(1):82–88.
11.Maggioni AP, Dahlstrom U, Filippatos G, Chioncel O, Leiro MC, Drozdz J, et al. EURObervational research programme: the HF pilot survey (ESC-HF Pilot). Eur J Heart Fail 2010;12(10):1076–1084.
12.Zannad F, Mebazaa A, Juilliere Y, Cohen-Solal A, Guize L, Alla F, et al. Clinical profile, contemporary management and one-year mortality in patients with severe acute HF syndromes: the EFICA study. Eur J Heart Fail 2006;8:697–705.
13.Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute HF patients: description of population. Eur Heart J 2006;27:2725–2736.
14.Spinar J, Parenica J, Vitovec J, Widimsky P, Linhart A, Fedorco M, et al. Baseline characteristics and hospital mortality in the acute HF database (AHEAD) main registry. Crit Care 2011;15:1–13.
15.Hamaguchi S, Kinugawa S, Tsuchihashi-Makaya M, Goto K, Yamada S, Yokoshita A, et al. Loop diuretic use at discharge is associated with adverse outcomes in hospitalized patients with HF: a report from the Japanese cardiac registry of HF in cardiology (JCARE-CARD). Circ J 2012;76:1920–1927.
16.Sato N, Kajimoto K, Keida T, Mizuno M, Minami Y, Yumino D, et al. Clinical features and outcome in hospitalized HF in Japan (from the ATTEND registry). Circ J 2013;77:944–951.
17.Youn YJ, Yoo BS, Lee JW, Kim JY, Han SW, Jeon ES, et al. Treatment performance measures affect clinical outcomes in patients with acute systolic failure: report from the Korean Heart Failure Registry. Circ J 2012;76:1151–1158.
18.Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A. Growing epidemic of coronary heart disease in low- and middleincome countries. Curr Probl Cardiol. 2010:35(2):72–115.P
19.Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, et al. The global health and economic burden of hospitalizations for HF: lessons learned from AHF registries. J Am Coll Cardiol. doi:10.1016/j.jacc.2013.11.053. Published online ahead of print 27 January 2014.
20.O’Connor CM, Miller AB, Blair JEA, Konstam MA, Wedge P, Bahit MC, et al. Causes of death and rehospitalization in patients hospitalized with worsening HF and reduced left ventricular ejection fraction: results from efficacy of vasopressin antagonism in HF outcome study with tolvaptan (EVEREST) program. Am Heart J 2010;159:841–849.
21.Maggioni AP, Dahlstorm U, Filippatos G, Chioncel O, Leiro MC, Drozdz J, et al. EURObservational research programme: regional differences and 1-year follow-up results of the HF pilot survey (ESC-HF Pilot). Eur J Heart Fail 2013;15:808–817.
22.Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, et al. Executive summary of the guidelines on the diagnosis and treatment of acute HF. Eur Heart J 2005;26:384–416.
23.Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, et al. Factors identified as precipitating hospital admissions for HF and clinical outcomes: findings from OPTIMIZE - HF. Arch Intern Med 2008;168:847–854.
24.Kannel WB, Gordon T. Evaluation of cardiovascular risk in the elderly: the Framingham study. Bull N Y Acad Med 1978;54:573–591.
25.Patients overly reliant on emergency services: NHIA. Taipei Times. 2014 Apr 7; p 3.
26.Rainer T. Why are Hong Kong’s emergency departments so understaffed? Emergency Physicians international. Issue 11.
27.Komindr A, Baugh CW, Grossman SA, Bohan JS. Key operational characteristics in emergency department observation units: a comparative study between sites in the United States and Asia. International Journal of Emergency Medicine 2014;7:1–8.
28.Teerklink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, et al. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomized, placebo-controlled trial. Lancet 2013;381:29–39.
29.Cowie M, Bell D, Butler J, Dargie H, Gray A, McDonagh T, et al. Acute heart failure - a call to action. Br J Cardiol 2013;20(suppl 2):S1–S11.
30.Collins SP, Levy PD, Pang PS, Gheorghiade M. The role of the emergency department in acute HF clinical trials - enriching patient identification and enrollment. Am Heart J 2013;165:902–909.
31.Chatterjee K, Massie B. Systolic and diastolic HF: differences and similarities. J Card Fail 2007;13:569–576.
32.Data.worldbank.org [homepage on the Internet]. Available from: http://data.worldbank.org/indicator/SP.POP.65UP.TO.ZS/countries?display=default/. Accessed April 25, 2014.
33.Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of HF with preserved ejection fraction. N Engl J Med 2006;335:251–259.
34.Borlaug BA, Paulus WJ. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J; doi:10.1093/eurheartj/ehq426. Published online ahead of print 7 December 2010
35.Stewart S, Pearson S, Horowitz JD. Effects of a home-based intervention among patients with congestive HF discharged from acute hospital care. Arch Intern Med 1998;158:1067–1072.
36.Wang SP, Lin LC, Lee CM, Wu, SC. Effectiveness of a selfcare program in improving symptom distress and quality of life in congestive HF patients: a preliminary study. J Nurs Res 2011:19:257–266.
37.Makaya MT, Kato N, Chishaki A, Takeshita A, Tsutsui H. Anxiety and poor society support are independently associated with adverse outcomes in patients with mild HF. Circ J 2009;73:280–287.
38.Blair JEA, Zannad F, Konstam MA, Cook T, Traver B, Burnett JC Jr, et al. Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening HF. J Am Coll Cardiol 2008;52:1640–1648.
39.Butler J, Subacius H, Vaduganathan M, Fonarow GC, Ambrosy AP, Konstam MA, et al. Relationship between clinical trial site enrollment with participant characteristics, protocol completion and, outcomes. J Am Coll Cardiol 2013;61:571–579.